54 results
8-K
EX-3.1
CORT
Corcept Therapeutics Inc
11 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:34pm
are commonly incident to the office of chief executive or which are delegated to him or her by the Board of Directors. The Chief Executive Officer
8-K
EX-1.1
CORT
Corcept Therapeutics Inc
6 Jul 12
Corcept Therapeutics Commences Public Offering of Common Stock
12:00am
)Payment of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including any filing fees … of airplanes, fees and expenses incident to listing the Offered Securities on the NASDAQ Stock Market and other national and foreign exchanges, fees
8-K
EX-4.2
h1vawyriz
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
5azfj
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
EX-10.1
b4djtq
29 Mar 12
Corcept Therapeutics Announces Exercise of Warrants
12:00am
8-K
EX-1.1
auvgdc8n41 79
21 Jan 11
Corcept Therapeutics Announces Pricing of $39.0 Million
12:00am
10-K/A
2lc9mofl
19 Aug 10
Annual report (amended)
12:00am
8-K
EX-1.1
fxvaxxf
25 Jun 10
Corcept Therapeutics Announces Pricing of $15 Million
12:00am
8-K
EX-4.2
ahhfoe7jo
23 Apr 10
Corcept Therapeutics Announces Exercise of Existing Warrants
12:00am
8-K
EX-10.1
wemo h8a5
23 Apr 10
Corcept Therapeutics Announces Exercise of Existing Warrants
12:00am